SAN DIEGO -- REVA Medical, LLC announced the successful completion of a live case demonstration featuring the MOTIV® sirolimus-eluting bioresorbable vascular scaffold and the presentation of late-breaking clinical results from the...
SAN DIEGO -- REVA Medical, LLC announced the successful completion of a live case demonstration featuring the MOTIV® sirolimus-eluting bioresorbable vascular scaffold and the presentation of late-breaking clinical results from the...
Final late-breaking VIVA26 studies reported new data on the Revello™ covered stent for iliac artery disease, Neuroguard IEP carotid stenting outcomes, and early real-world use of the Rotarex™ atherectomy system in CLTI.
Final late-breaking VIVA26 studies reported new data on the Revello™ covered stent for iliac artery disease, Neuroguard IEP carotid stenting outcomes, and early real-world use of the Rotarex™ atherectomy system in CLTI.
Late-breaking VIVA26 studies reported on IVL for calcified PAD, transdermal oxygen therapy after LE revascularization, transcatheter arterialization for no-option CLTI, and DES outcomes in complex femoropopliteal disease.
Late-breaking VIVA26 studies reported on IVL for calcified PAD, transdermal oxygen therapy after LE revascularization, transcatheter arterialization for no-option CLTI, and DES outcomes in complex femoropopliteal disease.
Six late-breaking VIVA26 studies reported new data on sirolimus-based balloon and resorbable scaffold therapies, as well as adjunctive pharmacologic treatment, for patients with PAD and chronic limb-threatening ischemia.
Six late-breaking VIVA26 studies reported new data on sirolimus-based balloon and resorbable scaffold therapies, as well as adjunctive pharmacologic treatment, for patients with PAD and chronic limb-threatening ischemia.
Data through 9 months of follow-up from this ongoing 36-month study demonstrate high vessel patency, low reintervention rates and meaningful improvements in mobility and symptoms, providing evidence supporting the treatment of complex iliac...
Data through 9 months of follow-up from this ongoing 36-month study demonstrate high vessel patency, low reintervention rates and meaningful improvements in mobility and symptoms, providing evidence supporting the treatment of complex iliac...
Newell and Oliver examine the clinical burden of PAD and the strategic, operational, financial, and regulatory considerations involved in developing ASC-based peripheral vascular programs.
Newell and Oliver examine the clinical burden of PAD and the strategic, operational, financial, and regulatory considerations involved in developing ASC-based peripheral vascular programs.
The longer-length Esprit addresses a real-world clinical need: most below-the-knee lesions in CLTI patients exceed 100 mm, while existing lengths can require multiple scaffolds, increasing procedural time and complexity.
The longer-length Esprit addresses a real-world clinical need: most below-the-knee lesions in CLTI patients exceed 100 mm, while existing lengths can require multiple scaffolds, increasing procedural time and complexity.
Dr. Robert L. Minor presents two complex cases of “global” renal and mesenteric ischemia in which right radial access improved visceral artery cannulation and guide support, avoided challenging aortoiliac anatomy, and facilitated multivessel...
Dr. Robert L. Minor presents two complex cases of “global” renal and mesenteric ischemia in which right radial access improved visceral artery cannulation and guide support, avoided challenging aortoiliac anatomy, and facilitated multivessel...
Sarah Misbah, MD; Alexis Albert Annan, MD; Sridevi Pitta, MD, MBA; Ashley Ferguson, RN, BSN
Misbah et al present the case of a 70-year-old female who presented with left lower extremity (LLE) critical limb ischemia (CLI) and underwent a bilateral SFA intervention via the transulnar route.
Misbah et al present the case of a 70-year-old female who presented with left lower extremity (LLE) critical limb ischemia (CLI) and underwent a bilateral SFA intervention via the transulnar route.
Jorge A. Miranda, MD; M. Laiq Raja, MD, FACC, FSCAI
The Rotarex™ Catheter System can help treat acute and subacute limb ischemia, in-stent restenosis, and mixed-morphology PAD lesions while supporting efficient, IVUS-guided revascularization.
The Rotarex™ Catheter System can help treat acute and subacute limb ischemia, in-stent restenosis, and mixed-morphology PAD lesions while supporting efficient, IVUS-guided revascularization.
Eric A. Secemsky, MD, MSc, RPVI, FACC, FAHA, FSCAI
Eric Secemsky, MD, discusses his AMP 2025 presentation entitled “Outcomes in Patients With and Without CLTI: A Systematic Literature Review on Atherectomy for Peripheral Interventions”.
Eric Secemsky, MD, discusses his AMP 2025 presentation entitled “Outcomes in Patients With and Without CLTI: A Systematic Literature Review on Atherectomy for Peripheral Interventions”.
Mike Watts, MD, FSIR, discusses his presentation on the use of wearables and artificial intelligence in the prevention and treatment of chronic limb-threatening ischemia.
Mike Watts, MD, FSIR, discusses his presentation on the use of wearables and artificial intelligence in the prevention and treatment of chronic limb-threatening ischemia.
Vascular surgeon Dr. Takahiro Tokuda, from Nagoya Heart Center in Japan, outlines new evidence comparing 2 contemporary revascularization options for heavily calcified femoropopliteal lesions
Vascular surgeon Dr. Takahiro Tokuda, from Nagoya Heart Center in Japan, outlines new evidence comparing 2 contemporary revascularization options for heavily calcified femoropopliteal lesions
"My concern about embolization during interventional procedures dates back almost 3 decades," says Dr. Bates. "While researching and developing one of the early carotid filter systems and as a co-inventor of carotid flow reversal, it became...
"My concern about embolization during interventional procedures dates back almost 3 decades," says Dr. Bates. "While researching and developing one of the early carotid filter systems and as a co-inventor of carotid flow reversal, it became...
"The DETOUR System (Endologix) and percutaneous transmural arterial bypass (PTAB) represents a truly exciting addition to our armamentarium for the treatment of complex peripheral artery disease (PAD) patients," says Jaafar A. Golzar, MD,...
"The DETOUR System (Endologix) and percutaneous transmural arterial bypass (PTAB) represents a truly exciting addition to our armamentarium for the treatment of complex peripheral artery disease (PAD) patients," says Jaafar A. Golzar, MD,...
Dr Ramon Varcoe discusses his ISET 2025 presentation on the efficacy and safety of bioresorbable drug-coated balloons in treating infrapopliteal arterial disease.
Dr Ramon Varcoe discusses his ISET 2025 presentation on the efficacy and safety of bioresorbable drug-coated balloons in treating infrapopliteal arterial disease.
At ISET 2025, Anvar Babaev, MD, PhD, presented findings from the Disrupt PAD BTK II study, a prospective, multicenter trial assessing the efficacy and safety of Shockwave IVL in treating calcified below-the-knee PAD.
At ISET 2025, Anvar Babaev, MD, PhD, presented findings from the Disrupt PAD BTK II study, a prospective, multicenter trial assessing the efficacy and safety of Shockwave IVL in treating calcified below-the-knee PAD.
The right clinical endpoint for assessing patency was discussed on Wednesday afternoon in a VIVA@LINC session by Raghu Kolluri, MD, System Medical Director at OhioHealth and President of Syntropic Core Lab in Ohio.
The right clinical endpoint for assessing patency was discussed on Wednesday afternoon in a VIVA@LINC session by Raghu Kolluri, MD, System Medical Director at OhioHealth and President of Syntropic Core Lab in Ohio.
Nicole Dellise, DNP, and Derek Pineda, FNP, describe their recent publication encouraging cardiovascular team members to publish and the importance of sharing their work with the broader community.
Nicole Dellise, DNP, and Derek Pineda, FNP, describe their recent publication encouraging cardiovascular team members to publish and the importance of sharing their work with the broader community.
Derek Pineda, FNP, CCRN, RCIS, AACC, shares thoughts from his presentation on drug-coated balloons at the TCT Nurse and Technologist Symposium, which took place in San Diego, California, on October 31, 2026.
Derek Pineda, FNP, CCRN, RCIS, AACC, shares thoughts from his presentation on drug-coated balloons at the TCT Nurse and Technologist Symposium, which took place in San Diego, California, on October 31, 2026.
Cristina Valdez, MSN, ACNP, presented "Cursed Vessels: Navigating the Nightmare of Coronary Calcification" at the October 31st Nurse and Technologist session at TCT 2026 in San Diego, California.
Cristina Valdez, MSN, ACNP, presented "Cursed Vessels: Navigating the Nightmare of Coronary Calcification" at the October 31st Nurse and Technologist session at TCT 2026 in San Diego, California.
A discussion by interventional cardiologists: Professors Javier Escaned and Yader Sandoval share their perspectives on the evolving role of CT-guided PCI and the innovations shaping the future of PCI planning and guidance.
A discussion by interventional cardiologists: Professors Javier Escaned and Yader Sandoval share their perspectives on the evolving role of CT-guided PCI and the innovations shaping the future of PCI planning and guidance.
"STEMI: The Stakes": A video presentation by Sameer Mehta, MD, at the March 8th Nurse & Technologist Symposium at CRT 2026, held March 7-10 in Washington, D.C.
"STEMI: The Stakes": A video presentation by Sameer Mehta, MD, at the March 8th Nurse & Technologist Symposium at CRT 2026, held March 7-10 in Washington, D.C.
Dr. Alaswad reflects on how complex PCI is moving into longer, more calcified, higher-risk cases. Cumulative radiation exposure and the physical toll of protection are becoming career-defining issues. Protecting the team is not optional.
Dr. Alaswad reflects on how complex PCI is moving into longer, more calcified, higher-risk cases. Cumulative radiation exposure and the physical toll of protection are becoming career-defining issues. Protecting the team is not optional.
What does it look like to run a modern cath lab outside the U.S.? Jason Money, RN, RCIS, shares a unique perspective shaped by more than two decades working in New Zealand’s public healthcare system.
What does it look like to run a modern cath lab outside the U.S.? Jason Money, RN, RCIS, shares a unique perspective shaped by more than two decades working in New Zealand’s public healthcare system.
Brian C. Case, MD; Bailey Ann Richardson, MSN, AGNP, RN-BC, RNFA, CNOR, RCIS
Bailey Richardson, MSN, speaks with Brian Case, MD, about coronary microvascular dysfunction and why “normal” angiography can miss the cause of symptoms in patients with angina with non-obstructive coronary arteries (ANOCA).
Bailey Richardson, MSN, speaks with Brian Case, MD, about coronary microvascular dysfunction and why “normal” angiography can miss the cause of symptoms in patients with angina with non-obstructive coronary arteries (ANOCA).
